Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
about
The Pathophysiology of Moyamoya Disease: An UpdateResearch Progress of Moyamoya Disease in ChildrenRole of Ring Finger Protein 213 in Moyamoya DiseaseA new horizon of moyamoya disease and associated health risks explored through RNF213Vascular diseases await translation of blood vessels engineered from stem cellsMoyamoya disease and syndromes: from genetics to clinical managementMoyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cellsBiochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In VivoSignificant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery diseaseGenetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility GeneSerum miRNA signature in Moyamoya disease.The pathobiology of vascular malformations: insights from human and model organism genetics.Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells.Repeated de novo aneurysm formation after anastomotic surgery: Potential risk of genetic variant RNF213 c.14576G>A.Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya DiseaseCellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome SequencingProposal for a Prospective Registry for Moyamoya Disease in Japan.Recent advances in moyamoya disease: pathophysiology and treatment.A pathologist's perspective on induced pluripotent stem cells.RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population.The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G>A Variant (rs112735431).Securin promotes migration and invasion via matrix metalloproteinases in glioma cellsRare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders.Dysregulation of RNF213 promotes cerebral hypoperfusion.Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice.Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell lineArgininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension
P2860
Q26769012-C3147FF8-CC1C-4CD2-8055-20B630672195Q26800982-738942E2-5D18-46DC-BB5B-DF04CB2BC016Q28066103-EC080845-03DA-4C3D-98D5-F578D614CBFFQ28080728-BCD3D74B-0F53-4750-868F-63B44DFFFF1BQ28083072-EF4005EE-EF69-4A0E-8A39-F19DD1D869F2Q28086795-3D6B390C-D6C3-4A49-85D4-57AD87A64AAEQ28116611-627464CA-ACAF-4118-A45C-4F2B764069FBQ28118678-61BFB759-44D6-4BBE-A684-787AB77B8F1EQ33570495-14BA02A0-A87D-4573-A7F9-FDD1EC8798C9Q33765867-426D8C79-B751-4C29-831A-2AB34E62F5A6Q34004659-78EFBAF8-15A2-4157-8D66-7C84C337B896Q34544980-E8BF40C1-4881-40F2-B868-9AD6791F503FQ34577527-C349BAE2-E74C-45B3-A8C4-85FF94448C50Q35355412-D8B49279-1D12-423E-AF36-B63FAE9DF441Q36141373-E924A2AB-E43F-4AC4-B52E-BEA853EE36BAQ36142971-B0BA74D0-1D1D-46BB-95AE-A522901790A1Q36162869-95905921-C263-43C5-BDF2-C1F563E01EB9Q36440411-191B33FB-7F1D-41AF-B5E1-7D65E525BD4FQ37686325-2D74AA19-DA1E-4590-B9E6-29357074D6D0Q38169079-15E5C159-60E5-448E-ABF3-DA5AAF2B7F11Q38649378-F8AEDE86-44A7-44C8-AC32-553CA9BE6587Q39286785-64A29516-8F46-403E-A3D6-03FAEDE203B2Q40021680-28162819-52E9-4DBC-AF7F-A5E818945E7DQ41994227-E558605B-DC8D-4F8B-8EBF-50DA4EC3FF71Q42419683-9A5280A8-115C-47A4-A5D6-7AB5A0F691D4Q47145221-0CBD2433-60C7-4001-B9C2-47060603AA70Q50329951-DD70427D-2CCD-4EE8-8AF6-9BE05120BB70Q51747256-B35BFEB0-3F66-4020-9C66-D968F65526EDQ55336818-E1178852-7DE9-49E8-BBE6-10E8928C214AQ57166852-D4AEF59C-2EC3-4B14-A795-867A446E7CBCQ58335877-5668F753-33DD-47AF-8A5D-FFBAEC059AD5
P2860
Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Downregulation of Securin by t ...... cells from moyamoya patients.
@en
Downregulation of Securin by t ...... cells from moyamoya patients.
@nl
type
label
Downregulation of Securin by t ...... cells from moyamoya patients.
@en
Downregulation of Securin by t ...... cells from moyamoya patients.
@nl
prefLabel
Downregulation of Securin by t ...... cells from moyamoya patients.
@en
Downregulation of Securin by t ...... cells from moyamoya patients.
@nl
P2093
P1476
Downregulation of Securin by t ...... l cells from moyamoya patients
@en
P2093
Akio Koizumi
Akira Watanabe
Daisuke Taura
Fumihiko Shiota
Hiroko Okuda
Hirokuni Hashikata
Isao Asaka
Kazuwa Nakao
Kenji Osafune
Kouji H Harada
P356
10.1016/J.BBRC.2013.07.004
P407
P577
2013-07-12T00:00:00Z